SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

10 hedge funds and large institutions have $2.64M invested in Seelos Therapeutics, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more funds holding in top 10

Funds holding in top 10: →

less capital invested

Capital invested by funds: $ → $
Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$731K
2
+$468K
3
+$71K
4
Citadel Advisors
Citadel Advisors
Florida
+$63K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$47.3K

Top Sellers

1
-$64K
2
-$53K
3
-$47K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$45K
5
Northern Trust
Northern Trust
Illinois
-$28K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$796K
2
$731K
3
$587K
4
$189K
5
$71K
6
$63K
7
$41K
8
$36K
9
$33K
10
$29K
11
$14.7K
12
$10K
13
$10K
14
$6K
15
$5K
16
$4K
17
$4K
18
$4K
19
$1K
20
$1K
21
–
22
–
23
–
24
–
25
–
1
2